Abramowitz kenneth - see footnote investment history in Power medical interventions inc

Filed on 2007-11-02 by Abramowitz Kenneth SEC CIK 1234710 Form 4

Accession 0001104659-07-079332.txt Sec File: edgar/data/1234710/0001104659-07-079332-index.htm

2007-10-31 Abramowitz Kenneth (CIK 1234710) through See Footnote

Invested in Power Medical Interventions Inc sold 3742609 shares at $0.00 remaining shares owned 0

Series C Convertible Preferred Stock Power Medical Interventions Inc Pmii underlying security shares 233853 underlying security title Common Stock

f4 securities held by ngn biomed opportunity i gmbh & co. beteiligungs kg. the reporting person is managing general partner of ngn capital, the managing limited partner of ngn biomed opportunity i gmbh & co. beteiligungs kg. the reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of section 16 or for any other purpose.
f2 series c convertible preferred stock of power medical interventions, inc. was converted into common stock upon completion of the issuer's initial public offering which closed on october 31, 2007. the series c convertible preferred stock converted into common stock at the conversion rate of 16 for 1, which reflects the company's reverse stock split on october 5, 2007.


Filed on 2007-11-02 by Abramowitz Kenneth SEC CIK 1234710 Form 4

Accession 0001104659-07-079332.txt Sec File: edgar/data/1234710/0001104659-07-079332-index.htm

2007-10-31 Abramowitz Kenneth (CIK 1234710) through See Footnote

Invested in Power Medical Interventions Inc sold 5176860 shares at $0.00 remaining shares owned 0

Series C Convertible Preferred Stock Power Medical Interventions Inc Pmii underlying security shares 323471 underlying security title Common Stock

f3 securities held by ngn biomed opportunity i, l.p. the reporting person is managing general partner of ngn capital, the general partner of ngn biomed i gp, l.p, which is the general partner of ngn biomed opportunity i, l.p. the reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of section 16 or for any other purpose.
f2 series c convertible preferred stock of power medical interventions, inc. was converted into common stock upon completion of the issuer's initial public offering which closed on october 31, 2007. the series c convertible preferred stock converted into common stock at the conversion rate of 16 for 1, which reflects the company's reverse stock split on october 5, 2007.


Filed on 2007-11-02 by Abramowitz Kenneth SEC CIK 1234710 Form 4

Accession 0001104659-07-079332.txt Sec File: edgar/data/1234710/0001104659-07-079332-index.htm

2007-10-31 Abramowitz Kenneth (CIK 1234710) through See Footnote

Invested in Power Medical Interventions Inc sold 3985346 shares at $0.00 remaining shares owned 0

Series B Convertible Preferred Stock Power Medical Interventions Inc Pmii underlying security shares 249126 underlying security title Common Stock

f4 securities held by ngn biomed opportunity i gmbh & co. beteiligungs kg. the reporting person is managing general partner of ngn capital, the managing limited partner of ngn biomed opportunity i gmbh & co. beteiligungs kg. the reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of section 16 or for any other purpose.
f1 series b convertible preferred stock of power medical interventions, inc. was converted into common stock upon completion of the issuer's initial public offering which closed on october 31, 2007. the series b convertible preferred stock converted into common stock at the conversion rate of 16 for 1, which reflects the company's reverse stock split on october 5, 2007.


Filed on 2007-11-02 by Abramowitz Kenneth SEC CIK 1234710 Form 4

Accession 0001104659-07-079332.txt Sec File: edgar/data/1234710/0001104659-07-079332-index.htm

2007-10-31 Abramowitz Kenneth (CIK 1234710) through See Footnote

Invested in Power Medical Interventions Inc sold 5512618 shares at $0.00 remaining shares owned 0

Series B Convertible Preferred Stock Power Medical Interventions Inc Pmii underlying security shares 344597 underlying security title Common Stock

f3 securities held by ngn biomed opportunity i, l.p. the reporting person is managing general partner of ngn capital, the general partner of ngn biomed i gp, l.p, which is the general partner of ngn biomed opportunity i, l.p. the reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of section 16 or for any other purpose.
f1 series b convertible preferred stock of power medical interventions, inc. was converted into common stock upon completion of the issuer's initial public offering which closed on october 31, 2007. the series b convertible preferred stock converted into common stock at the conversion rate of 16 for 1, which reflects the company's reverse stock split on october 5, 2007.


Filed on 2007-11-02 by Abramowitz Kenneth SEC CIK 1234710 Form 4

Accession 0001104659-07-079332.txt Sec File: edgar/data/1234710/0001104659-07-079332-index.htm

2007-10-31 Abramowitz Kenneth (CIK 1234710) through See Footnote

Invested in Power Medical Interventions Inc bought 482979 shares remaining shares owned 1151047

Common Stock Power Medical Interventions Inc Pmii Transaction code: C Conversion of derivative security (usually options)

f1 series b convertible preferred stock of power medical interventions, inc. was converted into common stock upon completion of the issuer's initial public offering which closed on october 31, 2007. the series b convertible preferred stock converted into common stock at the conversion rate of 16 for 1, which reflects the company's reverse stock split on october 5, 2007.
f2 series c convertible preferred stock of power medical interventions, inc. was converted into common stock upon completion of the issuer's initial public offering which closed on october 31, 2007. the series c convertible preferred stock converted into common stock at the conversion rate of 16 for 1, which reflects the company's reverse stock split on october 5, 2007.
f4 securities held by ngn biomed opportunity i gmbh & co. beteiligungs kg. the reporting person is managing general partner of ngn capital, the managing limited partner of ngn biomed opportunity i gmbh & co. beteiligungs kg. the reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of section 16 or for any other purpose.


Filed on 2007-11-02 by Abramowitz Kenneth SEC CIK 1234710 Form 4

Accession 0001104659-07-079332.txt Sec File: edgar/data/1234710/0001104659-07-079332-index.htm

2007-10-31 Abramowitz Kenneth (CIK 1234710) through See Footnote

Invested in Power Medical Interventions Inc bought 668068 shares remaining shares owned 1151047

Common Stock Power Medical Interventions Inc Pmii Transaction code: C Conversion of derivative security (usually options)

f1 series b convertible preferred stock of power medical interventions, inc. was converted into common stock upon completion of the issuer's initial public offering which closed on october 31, 2007. the series b convertible preferred stock converted into common stock at the conversion rate of 16 for 1, which reflects the company's reverse stock split on october 5, 2007.
f2 series c convertible preferred stock of power medical interventions, inc. was converted into common stock upon completion of the issuer's initial public offering which closed on october 31, 2007. the series c convertible preferred stock converted into common stock at the conversion rate of 16 for 1, which reflects the company's reverse stock split on october 5, 2007.
f3 securities held by ngn biomed opportunity i, l.p. the reporting person is managing general partner of ngn capital, the general partner of ngn biomed i gp, l.p, which is the general partner of ngn biomed opportunity i, l.p. the reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of section 16 or for any other purpose.